文献速递免疫规划

展示寨卡病毒潜在B细胞表位的噬菌体病毒样颗粒免疫可中和猴肾细胞寨卡病毒感染

Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
PubMed 文献 · Vaccine · 2018-02-01

研究将寨卡病毒包膜蛋白的6个潜在B细胞表位展示在MS2、PP7和Qβ噬菌体病毒样颗粒上,评估小鼠免疫原性。混合VLPs免疫小鼠产生抗寨卡抗体,但未抵抗高剂量攻击;低滴度血清在体外中和低剂量寨卡病毒。

要点

  • 展示寨卡病毒包膜B细胞表位的Qβ VLPs在小鼠中具有免疫原性。
  • 混合VLPs免疫小鼠未抵抗高剂量寨卡病毒攻击。
  • 免疫小鼠血清在体外中和低剂量寨卡病毒,但滴度低。

核心结论

  • 这些表位是B细胞表位,展示在Qβ VLP平台时具有免疫原性。
  • 展示单个B细胞表位的VLPs免疫对寨卡病毒感染仅有轻微降低作用。
  • 展示多个B细胞表位组合的混合VLPs免疫可中和寨卡病毒感染,是增强中和的良好策略。

研究设计与样本

  • 将寨卡病毒包膜蛋白的潜在B细胞表位(氨基酸241-259、294-315、317-327、346-361、377-388和421-437)展示在MS2、PP7和Qβ噬菌体病毒样颗粒平台上,并在小鼠中评估免疫原性。

主要发现

  • 用展示寨卡病毒包膜B细胞表位的混合VLPs免疫的小鼠产生了抗寨卡病毒抗体。
  • 免疫小鼠未受到针对高攻击剂量寨卡病毒的保护。
  • 免疫小鼠的血清(尽管滴度低)在体外中和了低剂量寨卡病毒。

局限性

  • 免疫小鼠未受到针对高攻击剂量寨卡病毒的保护。
  • 免疫小鼠血清中和寨卡病毒的滴度低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Zika virus (ZIKV) is a mosquito-borne flavivirus that has re-emerged and is associated with many debilitating clinical manifestations. Research is currently being conducted to develop a prophylactic vaccine against the virus; however, there has not been any licensed ZIKV vaccine. Recent studies have identified potential B-cell epitopes (amino acids 241-259, 294-315, 317-327, 346-361, 377-388 and 421-437) on the envelope protein of ZIKV, which could be explored to develop peptide vaccines against ZIKV infection. Nevertheless, the immunogenicity of these epitopes has never been assessed. Here, we displayed these epitopes on highly immunogenic bacteriophage virus-like particles (VLPs; MS2, PP7 and Qβ) platforms and assessed their immunogenicity in mice. Mice immunized with a mixture of VLPs displaying ZIKV envelope B-cell epitopes elicited anti-ZIKV antibodies. Although, immunized mice were not protected against a high challenge dose of ZIKV, sera - albeit at low titers - from immunized mice neutralized (in vitro) a low dose of ZIKV. Taken together, these results show that these epitopes are B-cell epitopes and they are immunogenic when displayed on a Qβ VLP platform. Furthermore, the results also show that immunization with VLPs displaying a single B-cell epitope minimally reduces ZIKV infection whereas immunization with a mixture of VLPs displaying a combination of the B-cell epitopes neutralizes ZIKV infection. Thus, immunization with a mixture of VLPs displaying multiple ZIKV B-cell epitopes is a good strategy to enhance ZIKV neutralization.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Basu R, Zhai L, Contreras A, et al. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells. Vaccine. 2018. PMID: 29395533. doi:10.1016/j.vaccine.2018.01.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。